Using a Genetically Modified Human IPS Line to Screen for Drugs that Prevent or Treat Alzheimer's Disease
Invention type: Technology
/
Case number: #26292P
Researchers
Li-Huei Tsai
/
TaeHyun Kim
/
Leyla Akay
/
Matheus Victor
/
Masayuki Nakano
Departments: DLC Heads Science, Picower Institute for Learning & Memory, Brain and Cognitive Sciences
Technology Areas: Drug Discovery and Research Tools: Cell Lines & Organoids / Therapeutics: Small Molecules
Impact Areas: Healthy Living
-
methods for treating alzheimer's disease and related tools
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.